BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1934804)

  • 1. Absent or faint renal uptake on bone scan. Etiology and significance in metastatic bone disease.
    Kim SE; Kim DY; Lee DS; Chung JK; Lee MC; Koh CS
    Clin Nucl Med; 1991 Aug; 16(8):545-9. PubMed ID: 1934804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH; Holman BL
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of solitary hot spots of bone scintigraphy in patients with extraskeletal malignancies].
    Tomoda Y; Ishino Y; Nakata H
    Kaku Igaku; 2001 Nov; 38(6):721-6. PubMed ID: 11806083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of the superscan in prostatic bone scintigraphy.
    Constable AR; Cranage RW
    Br J Radiol; 1981 Feb; 54(638):122-5. PubMed ID: 7459549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern and distribution of bone metastases in common malignant tumors.
    Kakhki VR; Anvari K; Sadeghi R; Mahmoudian AS; Torabian-Kakhki M
    Nucl Med Rev Cent East Eur; 2013; 16(2):66-9. PubMed ID: 24068635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal scintigraphy.
    McDougall IR
    West J Med; 1979 Jun; 130(6):503-14. PubMed ID: 390886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective study of renal images on bone scans].
    Murayama T; Munakata A; Narita K; Fujita K; Fujii K
    Rinsho Hoshasen; 1989 Mar; 34(3):335-8. PubMed ID: 2739084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclide bone scan in initial staging of breast cancer.
    Boughattas S; Hassine H; Chatti K; Essabbah H
    Tunis Med; 2003 Mar; 81(3):156-61. PubMed ID: 12793064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioisotope bone scanning characteristics of metastatic skeletal deposits of prostatic adenocarcinoma.
    Kane RD; Paulson DF
    J Urol; 1977 May; 117(5):618-21. PubMed ID: 859203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of routine bone scintigraphy renal imaging in renal cell carcinoma.
    Chancellor MB; Konnak JW; Grossman HB
    Urology; 1989 May; 33(5):440-2. PubMed ID: 2775373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
    Nakamoto Y; Osman M; Wahl RL
    Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
    Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
    Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the prognosis of cancer patients with metastatic bone tumors based on serial bone scintigrams.
    Ohmori K; Matsui H; Yasuda T; Kanamori M; Yudoh K; Seto H; Tsuji H
    Jpn J Clin Oncol; 1997 Aug; 27(4):263-7. PubMed ID: 9379516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
    J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls of absent or faint kidney sign or bone scan.
    Constable AR; Cranage RW
    J Nucl Med; 1981 Jul; 22(7):658. PubMed ID: 6454765
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
    Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients.
    Umeda T; Koizumi M; Fukai S; Miyaji N; Motegi K; Nakazawa S; Takiguchi T
    Ann Nucl Med; 2018 Feb; 32(2):105-113. PubMed ID: 29243019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cancer of the prostate: value of bone scintigraphy. Point of view].
    Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
    Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absent kidney sign associated with symmetrical and uniformly increased uptake of radiopharmaceutical by the skeleton.
    Fogelman I; McKillop JH; Boyle IT; Greig WR
    Eur J Nucl Med; 1977 Dec; 2(4):257-9. PubMed ID: 415864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiologic Seminar CCXXXI: "poor renal sign" or "poor renal-super scan sign" in bone imaging.
    Lin DS
    J Miss State Med Assoc; 1983 Aug; 24(8):209-11. PubMed ID: 6620377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.